( en | de | ru )

 

Disambiguierung von "Westphal, Manfred"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
DNA methylation-based classification of central nervous system tumours.

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , und . Nat., 555 (7697): 469-474 (2018)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Manfred Westphal

Manfred Westphal

Manfred Westphal

Manfred Westphal

Manfred Westphal

 

Weitere Publikationen von Autoren mit dem selben Namen

DNA methylation-based classification of central nervous system tumours., , , , , , , , , und 133 andere Autor(en). Nat., 555 (7697): 469-474 (2018)End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey, , , , , , , , , und 7 andere Autor(en). Neuro-oncology, 15 (9): 1251–1256 (2013)Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network, , , , , , , , , und 8 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (34): 5743–5750 (2009)Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups, , , , , , , , , und 22 andere Autor(en). Acta Neuropathologica, 129 (5): 679--693 (01.05.2015)Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations, , , , , , , , , und 1 andere Autor(en). Clinical cancer research : an official journal of the American Association for Cancer Research, 19 (18): 5146–5157 (2013)Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas, , , , , , , , , und 3 andere Autor(en). International journal of cancer. Journal international du cancer, 129 (3): 659–670 (2011)Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?, , , , , , , , , und 3 andere Autor(en). Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (23): 6933–6937 (2007)Predictive impact of MGMT promoter methylation in glioblastoma of the elderly, , , , , , , , , und 1 andere Autor(en). International journal of cancer. Journal international du cancer, 131 (6): 1342–1350 (2012)Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation, , , , , , , , , und 9 andere Autor(en). Neurology, 81 (17): 1515–1522 (2013)Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas, , , , , , , , , und 4 andere Autor(en). Acta neuropathologica, 120 (6): 707–718 (2010)